Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Author:
Funder
U.S. Food and Drug Administration
Publisher
Elsevier BV
Reference261 articles.
1. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017;Xie;Respir. Res.,2020
2. Applying quality by design approach for the determination of potent paclitaxel loaded poly(lactic acid) based implants for localized tumor drug delivery;Özcan Bülbül;Int. J. Polym. Mater. Polym. Biomater.,2022
3. Cancer statistics;Siegel;CA. Cancer J. Clin.,2018
4. Years of life lost due to chronic obstructive pulmonary disease in Khuzestan province during 2011–2019: a population-based study;Azarbakhsh;Lung India,2023
5. Appropriateness of chronic asthma management and medication adherence in patients visiting ambulatory clinic of Gondar University Hospital: a cross-sectional study;Tesfaye;World Allergy Organ. J.,2018
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Revolutionizing Lung Cancer Treatment with Smart Pulmonary Drug Delivery Nanosystems;Journal of Drug Delivery Science and Technology;2024-09
2. Multifunctional nano-in-microparticles for targeted lung cancer cells: Synthesis, characterization and efficacy assessment;Materials Today Chemistry;2024-06
3. Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System;Molecules;2024-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3